[go: up one dir, main page]

Dyskinesias

"Dyskinesias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.


expand / collapse Publications
This graph shows the total number of publications written about "Dyskinesias" by people in this website by year, and whether "Dyskinesias" was a major or minor topic of these publications.
Below are the most recent publications written about "Dyskinesias" by people in Profiles.
  1. Motor network gamma oscillations in chronic home recordings predict dyskinesia in Parkinson's disease. Brain. 2024 Jun 03; 147(6):2038-2052.
    View in: PubMed
  2. Focused Ultrasound for Treatment of Movement Disorders: A Review of Non-Food and Drug Administration Approved Indications. Stereotact Funct Neurosurg. 2024; 102(2):93-108.
    View in: PubMed
  3. The case of a 49-year-old man with involuntary toe movements. Ann Clin Transl Neurol. 2023 07; 10(7):1260.
    View in: PubMed
  4. Protocol of a randomized controlled trial investigating Deep Brain Stimulation for MOtor symptoms in patients with Parkinson's disease DEmentia (DBS-MODE). BMC Neurol. 2023 Apr 21; 23(1):160.
    View in: PubMed
  5. Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. Lancet Neurol. 2022 12; 21(12):1099-1109.
    View in: PubMed
  6. Striatal Indirect Pathway Dysfunction Underlies Motor Deficits in a Mouse Model of Paroxysmal Dyskinesia. J Neurosci. 2022 03 30; 42(13):2835-2848.
    View in: PubMed
  7. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun. 2021 07 12; 12(1):4251.
    View in: PubMed
  8. Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson's Disease Cohorts. J Parkinsons Dis. 2021; 11(4):1569-1578.
    View in: PubMed
  9. The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats. Neurobiol Dis. 2021 01; 148:105175.
    View in: PubMed
  10. Movement Disorders in Chronic Kidney Disease - A Descriptive Review. J Stroke Cerebrovasc Dis. 2021 Sep; 30(9):105408.
    View in: PubMed